{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:47:20Z","timestamp":1789163240611,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.seizure.2021.09.011","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T15:41:38Z","timestamp":1631806898000},"page":"216-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Seizures in myelin oligodendrocyte glycoprotein antibody-associated disorders and related immune factors"],"prefix":"10.1016","volume":"92","author":[{"given":"Kang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seizure.2021.09.011_bib0001","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O'Connor","year":"2007","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.seizure.2021.09.011_bib0002","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2021.09.011_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102011","article-title":"Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: two paradigmatic cases and a review of the literature","volume":"41","author":"Foiadelli","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.seizure.2021.09.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102168","article-title":"Improvement in recurrent anti-myelin oligodendrocyte glycoprotein antibody-positive cerebral cortical encephalitis not requiring anti-inflammatory therapy following the decrease in cytokine\/chemokine levels","volume":"43","author":"Takamatsu","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"10.1016\/j.seizure.2021.09.011_bib0005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2021.09.011_bib0006","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.seizure.2021.09.011_bib0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.msard.2018.11.007","article-title":"Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: a comparative cohort study","volume":"27","author":"Yao","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.seizure.2021.09.011_bib0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2021.09.011_bib0009","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.seizure.2021.09.011_bib0010","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome","volume":"266","author":"Budhram","year":"2019","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2021.09.011_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ene.13790","article-title":"Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China","volume":"26","author":"Wang","year":"2019","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2021.09.011_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.seizure.2021.09.011_bib0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-019-09586-5","article-title":"MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity","volume":"267","author":"Papathanasiou","year":"2020","journal-title":"J Neurol."},{"key":"10.1016\/j.seizure.2021.09.011_bib0014","article-title":"Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases.[J]","volume":"5","author":"Hofer","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.seizure.2021.09.011_bib0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","article-title":"CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.[J]","volume":"89","author":"Kaneko","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2021.09.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101394","article-title":"Atypical presentation of MOG-related disease: slowly progressive behavioral and personality changes following a seizure","volume":"36","author":"Y\u0131lmaz","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.seizure.2021.09.011_bib0017","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dmcn.14032","article-title":"Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children","volume":"61","author":"Ramanathan","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2021.09.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420945135","article-title":"Recent developments in MOG-IgG associated neurological disorders","volume":"13","author":"Hegen","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"10.1016\/j.seizure.2021.09.011_bib0019","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2021.09.011_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2018.06.028","article-title":"The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: a case report","volume":"392","author":"Ikeda","year":"2018","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.seizure.2021.09.011_bib0021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.0000000000002844","article-title":"Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD","volume":"87","author":"Wang","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2021.09.011_bib0022","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1212\/NXI.0000000000000335","article-title":"ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports","volume":"4","author":"K\u00f6rtv\u00e9lyessy","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"10.1016\/j.seizure.2021.09.011_bib0023","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458515622986","article-title":"Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case","volume":"22","author":"Jarius","year":"2016","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.seizure.2021.09.011_bib0024","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/08880018.2012.756564","article-title":"Prevalence and clinical significance of antithyroid antibodies in children with immune thrombocytopenic purpura","volume":"30","author":"Bay","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.seizure.2021.09.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102573","article-title":"Association between acute disseminated encephalomyelitis and thyroid autoimmunity in children","volume":"46","author":"Wang","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.seizure.2021.09.011_bib0026","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fneur.2019.01271","article-title":"Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously","volume":"10","author":"Ren","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.09.011_bib0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jocn.2019.07.049","article-title":"Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China","volume":"68","author":"Yao","year":"2019","journal-title":"J Clin Neurosci"}],"updated-by":[{"DOI":"10.1016\/j.seizure.2022.07.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T13:25:32Z","timestamp":1667309132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121003095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":27,"alternative-id":["S1059131121003095"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.09.011","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.seizure.2022.07.009","asserted-by":"object"}]},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizures in myelin oligodendrocyte glycoprotein antibody-associated disorders and related immune factors","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}